AI in Pharmacy Standards and Drug Supply Chain Upgrades | TWIRx
AI in Pharmacy Standards and Drug Supply Chain Upgrades This Week in Pharmacy — July 17, 2026 Artificial intelligence and supply chain modernization are reshaping pharmacy practice, patient access, and healthcare operations. In this episode of This Week in Pharmacy, host Todd Eury speaks with leaders from URAC and Cencora about responsible AI adoption and the growing gap between drug availability and real-world access. Guests Shawn Griffin, MD President and CEO, URAC Brent Wilhelm Senior Vice President, Global Supply Chain Center of Excellence, Cencora Tim Weber Pharmacy Operations and Regulatory Executive AI is already supporting clinical documentation, patient communication, risk prediction, and workflow automation. URAC President and CEO Shawn Griffin, MD, explains why healthcare organizations need clear governance, defined accountability, human oversight, and continuous monitoring before deploying AI at scale. The discussion addresses transparency, performance evaluation, bias, data integrity, cybersecurity, and the role accreditation standards may play in promoting safe and responsible AI adoption.
- Governance and accountability for AI outputs
- Human review of AI-supported decisions
- Monitoring safety, accuracy, and bias
- The role of accreditation in AI oversight
- Balancing innovation with patient protection
- Inventory visibility versus actual access
- Differences across pharmacies and sites of care
- Specialty and temperature-sensitive therapies
- Provider demand forecasting
- Reducing delays, shortages, and waste
You May Also Like

Anchorage News Today | 2 Min News | The Daily News Now!
The Daily News Now!

Follow the Money
VSiN
Podcasts von Tichys Einblick
Tichys Einblick

Le journal d'Europe 1
Europe 1

Ox news daily
Ox News

ながら日経
ラジオNIKKEI

700 WLW On-Demand
WLW-AM (WLWAM)

Tech News Daily
brief.news

SBS Vietnamese - SBS Việt ngữ
SBS

WSJ What’s News
The Wall Street Journal
Community discussion